ASH2018

Here's Why bluebird bio Shares Got Knocked Down 19.3% in December
Motley Fool
Sat, 01/5/19 - 12:05 am
Bluebird Bio
ASH2018
AMG 420
Amgen
Celgene scores at ASH18 with double luspatercept data
Pharmaforum
Mon, 12/3/18 - 10:00 am
Celgene
luspatercept
ASH2018
ASH18: Argenx pens $1.6B biobucks Janssen pact for blood cancer hopeful cusatuzumab
Fierce Biotech
Mon, 12/3/18 - 09:55 am
Argenx
Cilag
Janssen
cusatuzumab
ASH2018
blood cancers
ASH: Gilead, Novartis tout long-term data for CAR-T slow starters Yescarta, Kymriah
Fierce Pharma
Sun, 12/2/18 - 11:01 pm
Gilead
Novartis
CAR-T
Yescarta
Kymriah
ASH2018
ASH18: Bluebird's follow-on CAR-T finds initial success, but durability will be key test
Biopharma Dive
Sun, 12/2/18 - 10:50 pm
ASH2018
Bluebird Bio
CAR-T
bb21217
ASH18: CAR-T shows up in early CLL test
Biopharma Dive
Sun, 12/2/18 - 10:48 pm
Celgene
CAR-T
CLL
ASH2018
JCAR017
Top Biotech Stocks to Watch at ASH 2018
Yahoo/Motley Fool
Sun, 12/2/18 - 12:37 pm
ASH2018
Celgene
Bluebird Bio
Acceleron
ASH: Takeda maintenance data sets up Ninlaro for new myeloma nod
Fierce Pharma
Sun, 12/2/18 - 12:34 pm
ASH2018
Takeda
Ninlaro
Multiple Myeloma